(Q34360090)

1 August 2017

Interference of immune globulin with measles and rubella immunization. (English)

1 reference

1 August 2017

0 references

1 reference

1 reference

Siber GR

1

1 reference

1 August 2017

Werner BG

2

1 reference

1 August 2017

Halsey NA

3

1 reference

1 August 2017

Reid R

4

1 reference

1 August 2017

Almeido-Hill J

5

1 reference

1 August 2017

Garrett SC

6

1 reference

1 August 2017

Thompson C

7

1 reference

1 August 2017

Santosham M

8

1 reference

1 August 2017

language of work or name

English

0 references

publication date

1 February 1993

1 reference

The Journal of Pediatrics

1 August 2017

1 reference

1 August 2017

122

1 reference

1 August 2017

2

1 reference

1 August 2017

204-211

1 reference

Trial of high-titre human rubella immunoglobulin

1 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2806%2980114-9

Titered lots of immune globulin (Ig). Efficacy in the prevention of rubella

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2806%2980114-9

Response to measles vaccine in Haitian infants 6 to 12 months old. Influence of maternal antibodies, malnutrition, and concurrent illnesses.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2806%2980114-9

Need for measles revaccination in adolescents: correlation with birth date prior to 1972

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2806%2980114-9

Additional evidence against measles vaccine administration to infants less than 12 months of age: Altered immune response following active/passive immunization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2806%2980114-9

Measles antibody in previously immunized children. The need for revaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2806%2980114-9

Persistence of maternal antibody in infants beyond 12 months: mechanism of measles vaccine failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2806%2980114-9

VACCINATION OF INFANTS WITH LIVING ATTENUATED MEASLES VACCINE (EDMONSTON STRAIN) WITH AND WITHOUT GAMMA-GLOBULIN.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2806%2980114-9

Prevention of Haemophilus influenzae type b infections in high-risk infants treated with bacterial polysaccharide immune globulin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2806%2980114-9

Evaluation of bacterial polysaccharide immune globulin for the treatment or prevention of Haemophilus influenzae type b and pneumococcal disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2806%2980114-9

Measles antibody: reevaluation of protective titers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2806%2980114-9

Geographic variation in infant loss of maternal measles antibody and in prevalence of rubella antibody

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2806%2980114-9

Revaccination of previous recipients of killed measles vaccine: clinical and immunologic studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2806%2980114-9

Available rubella serologic tests

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2806%2980114-9

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0022-3476(06)80114-9

1 reference

1 August 2017

1 reference